InvestorsHub Logo
Followers 840
Posts 120458
Boards Moderated 18
Alias Born 09/05/2002

Re: jmkobers post# 15801

Thursday, 08/18/2016 11:18:30 AM

Thursday, August 18, 2016 11:18:30 AM

Post# of 20689

are you still holding to your contention of an "at risk" launch?

Yes, if TEVA has not obtained an injunction when the Hatch-Waxman stay expires in Feb 2017. (Provided, of course, that NVS/MNTA have received FDA approval for 40mg Copaxone.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”